Related Experiment Video
Updated: Jul 29, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
[The influence of chloroquine on some biochemical and hematological parameters in patients with critical limb
P Mondek1, R Slysko, V Sefránek
1Klinika cievnej chirurgie, Slovensý ústav srdcových a cievnych chorôb, Bratislava, Slovenská republika. mondo@pobox.sk
Insights
Critical limb ischemia (CLI) is a growing health issue. This study monitored hematological markers during reperfusion, investigating neutrophil-lymphocyte ratio and PMNL elastase to assess CLI severity.
Area of Science:
- Hematology
- Biochemistry
- Clinical Medicine
Context:
- Critical limb ischemia (CLI) presents a significant and escalating medical and social challenge.
- Estimated incidence of CLI ranges from 500 to 1000 cases per million inhabitants.
- Monitoring hematological and biochemical markers during reperfusion is crucial for managing CLI.
Purpose:
- To monitor key hematological and biochemical markers during reperfusion in patients with critical limb ischemia (CLI).
- To investigate the potential for medical intervention to influence polymorphonuclear neutrophil (PMNL) elastase levels.
- To evaluate the neutrophil-lymphocyte ratio (NLR) as a reliable indicator of clinical severity in CLI patients.
Summary:
- A clinical study conducted between 2000 and 2004 focused on patients with CLI undergoing reperfusion.
- The study monitored specific hematological and biochemical markers, including PMNL elastase and the NLR.
- The neutrophil-lymphocyte ratio was assessed for its utility in gauging the severity of the clinical condition.
Impact:
- Provides insights into hematological and biochemical changes during CLI reperfusion.
- Highlights the potential role of PMNL elastase modulation in CLI management.
- Establishes the neutrophil-lymphocyte ratio as a simple and reliable marker for assessing CLI severity.
Abstract:
CLI represents a major medical and social problem. The incidence is increasing and currently it was estimated 500-1000 per 1 million inhabitants. We carried out a clinical study (2000-2004) concerning monitoring of some hematological and biochemical markers during reperfusion in patients with CLI. The subject of our interest included possibilities to influence PMNL elastase by medical means and neutrophil-lymphocyte ratio which is considered a reliable and simple parameter to assess severity of clinical conditions.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care

